
Browsing restrictions can be lifted for a fee.
TCI Co., Ltd., an original design manufacturer company, engages in the research, development, manufactures, and sales of functional health food, food supplements, and skin care products. It offers liquid and solid supplements; immunity products; functional probiotics; basic nutrition; detox slimming; body health; sports nutrition supplements product; laundry detergents; hand sanitizers; and functional snacks, which includes, jelly, bars, chocolates, and gummies. It also provides skin care products, such as facial, body sheet, eye, and lip masks; essences; sprays; creams; and gels, as well as turnkey services. TCI Co., Ltd. was incorporated in 1980 and is headquartered in Taipei, Taiwan..
8436
大江
-1.55%
(-0.02)
The most recent financial report for 大江 (8436) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 8436's short-term business performance and financial health. For the latest updates on 8436's earnings releases, visit this page regularly.
According to historical valuation range analysis, 大江 (8436)'s current price-to-earnings (P/E) ratio is 11.17, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 大江 (8436) reported an Operating Profit of 303.57M with an Operating Margin of 17.45% this period, representing a growth of 24.61% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 大江 (8436) announced revenue of 1.74B, with a Year-Over-Year growth rate of -3.57%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 大江 (8436) held Total Cash and Cash Equivalents of 5.5B, accounting for 0.41 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 大江 (8436) achieved the “three margins increasing” benchmark, with a gross margin of 44.19%%, operating margin of 17.45%%, and net margin of 16.85%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 8436's profit trajectory and future growth potential.
According to the past four quarterly reports, 大江 (8436)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 2.5. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
大江 (8436)'s Free Cash Flow (FCF) for the period is -244.49M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 51.67% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.